Details of the Drug-Related molecule(s) Interaction Atlas

QCPOIDRINIAUKU-SRBBEKPSSA-N Drug Info

((1R,2R,3S,4R)-2,3-dihydroxy-4-([2-(1-naphthyl)pyrazolo[1,5-a]pyrimidin-7-yl]amino)cyclopentyl)methyl sulfamate; ((1R,2R,3S,4R)-2,3-dihydroxy-4-{[2-(1-naphthyl)pyrazolo[1,5-a]pyrimidin-7-yl]amino}cyclopentyl)methyl sulfamate; SCHEMBL15192059; QCPOIDRINIAUKU-SRBBEKPSSA-N

Cross-matching ID

PubChem CID

71666343

TTD Drug ID

DM4DJA7

General Information of Drug (ID: DM4DJA7)

Molecule-Related Drug Atlas

Molecule Type:

DTT

Drug Status:

Patented Agent(s)

Investigative Drug(s)

Download the Complete Related Drug List

Drug(s) Targeting Ubiquitin-activating enzyme E1 (UBAE1)

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
SCHEMBL15198145	DMKQ0GE	N. A.	N. A.	Patented	[1]
SCHEMBL15198146	DMHPQI2	N. A.	N. A.	Patented	[1]
PYZD-4409	DME0NO8	leukaemia	2A60-2B33	Investigative	[2]
------------------------------------------------------------------------------------

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
Ubiquitin-activating enzyme E1 (UBAE1)	TTXHWA7	UBA1_HUMAN	Inhibitor	[1]

------------------------------------------------------------------------------------

References

1	Pyrazolopyrimidinyl inhibitors of ubiquitin-activating enzyme. US10202389.
2	The ubiquitin-activating enzyme E1 as a therapeutic target for the treatment of leukemia and multiple myeloma. Blood. 2010 Mar 18;115(11):2251-9.